Bellevue F.(L)-B.Obesity Sol.B USD/ LU0415392322 /
| NAV2024-04-17 | Chg.-1.1600 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 492.6700USD | -0.23% | reinvestment | Equity Worldwide | Waystone M.Co.(Lux) ▶ |
GlobeNewswire
2016-07-12
Bellevue Asset Management : Biosimilars - an imperfect copy but a perfect investment
GlobeNewswire
2015-07-09
Bellevue Asset Management : Healthcare investments - new markets yield rich returns
